Mi Mi

发表

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer

Xin Zheng, Gang Wu, Liling Zhang, 2020, Journal of cellular and molecular medicine.

Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma

Juan Li, Liling Zhang, Zijian Liu, 2020, Medicine.

Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer

Chenyang Ye, Ying Yuan, Mi Mi, 2022, Signal Transduction and Targeted Therapy.

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma

Shanshan Weng, Chenyang Ye, Yier Lu, 2022, Frontiers in Genetics.

REV1: A novel biomarker and potential therapeutic target for various cancers

X. Fang, Shanshan Weng, N. Zhu, 2022, Frontiers in Genetics.

Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review

P. Ding, Nan Xiao, W. Mei, 2022, Frontiers in Immunology.

Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis

Gang Wu, Xinxiu Liu, Liling Zhang, 2019, Cancer management and research.

CMAR_A_185030 5209..5220

Gang Wu, Xinxiu Liu, Liling Zhang, 2019 .

lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network

Xin Zheng, Gang Wu, Liling Zhang, 2019, Front. Genet..

miR-30a/SOX4 Double Negative Feedback Loop is modulated by Disulfiram and regulates EMT and Stem Cell-like properties in Breast Cancer

Xin Zheng, Gang Wu, Liling Zhang, 2021, Journal of Cancer.

Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B‐cell lymphoma

Gang Wu, X. Lan, Juan Li, 2019, Cancer medicine.

Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer

Xin Zheng, Gang Wu, Liling Zhang, 2021, Frontiers in Oncology.

Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019

Shanshan Weng, N. Zhu, Jia Zheng, 2023, Frontiers in Oncology.

Global burden of tracheal, bronchus, and lung cancer attributable to occupational carcinogens in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019

Shanshan Weng, N. Zhu, Yier Lu, 2023, Annals of medicine.

Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label, single-arm, phase II trial

X. Fang, Jian Wang, Hongfeng Cao, 2023, EClinicalMedicine.

CSCO guidelines for colorectal cancer version 2023: Updates and insights.

Shanshan Weng, Hanguang Hu, Mi Mi, 2023, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Serum metabolomic profiling based on GC/MS helped to discriminate Diffuse Large B-cell Lymphoma patients with different prognosis.

Juan Li, Xin Zheng, Liling Zhang, 2021, Leukemia research.

Identification of hub genes and key pathways associated with angioimmunoblastic T-cell lymphoma using weighted gene co-expression network analysis

Gang Wu, Xinxiu Liu, Liling Zhang, 2019, Cancer management and research.